| 548 | - As adjunctive therapy in the treatment of patients with partial-onset seizures (POS) who have had an inadequate response or have significant intolerance to at least 2 other less costly anticonvulsant therapies (prior or current use); AND
- Patients are not receiving concurrent therapy with levetiracetam; AND
- Patients are under the care of a physician experienced in the treatment of epilepsy.
Note: Less costly anticonvulsant therapies may include the following:
Phenytoin, carbamazepine, gabapentin, lamotrigine, vigabatrin, topiramate, etc. |
